Global Device-Makers Want India To Harmonize Standards
Executive Summary
US medtech trade group AdvaMed is prodding the Indian government to harmonize what analysts have called “archaic” regulations governing medical devices with international standards, saying the result would be a win-win for both domestic and foreign companies.
You may also be interested in...
How J&J Hopes To Disrupt India's Diabetes Care Paradigm
Sushobhan Dasgupta, managing director of Johnson & Johnson Medical India, discusses how J&J's new go-to-market strategies are playing out, the role of e-commerce for medical devices in India, and how the company is leveraging its capabilities to provide solutions for the whole diabetic care pathway.
Top US Court Lifts Discovery Stay On Price-Fixing
The US Supreme Court has lifted a stay on document discovery in a multi-state lawsuit in which dozens of generics companies – including Teva, Mylan and Pfizer – are accused of price fixing. The ruling will allow a swathe of documents to be released in what Connecticut’s attorney general has said is potentially “the largest cartel case” in US history.
FDA Approves First Generic Of Daraprim
Daraprim, which saw its price jacked up by 4,000% by former drug company executive Martin Shkreli, now has a competitor with the US Food and Drug Administration’s approval of the first generic version of the nearly seven-decade-old drug used to treat a life-threatening parasitic infection known as toxoplasmosis.